The global liver health supplements market size was valued at USD 707.16 million in 2018 and is expected to register a CAGR of 4.32% during the forecast period. In recent years, changing lifestyle pattern has led to a rise in the consumption of fast food and alcohol, contributing to the high prevalence of liver diseases such as liver cancer, fatty liver disease, and others. According to the Centers for Disease Control & Prevention (CDC), in 2018, liver disease was diagnosed in nearly 4.5 million adults in the U.S. Thus, the rising prevalence of liver diseases has increased concerns among consumers about liver health, thereby driving the adoption of the supplements.
In the U.S., young adults with drinking habits generally consume supplements to maintain liver health. The rising inclination of consumers toward dietary supplements is expected to support the market growth in the forthcoming years. For instance, according to the data published by the Council for Responsible Nutrition (CRN) in September 2019, nearly 77% of Americans reported consumption of dietary supplements.
Various initiatives undertaken by the public and private organizations to increase the awareness among consumers about liver health is projected to support the market growth. In March 2019, Amsety, a nutrition company along with Fatty Liver Foundation launched the Kiss & Click campaign. It is designed to increase awareness regarding liver health. Similarly, the British Liver Trust runs campaigns to promote early diagnosis and intervention along with increasing awareness about all types of liver diseases. The Institute of Liver and Biliary Sciences (ILBS) based in Delhi, India undertakes various campaigns to increase awareness about hepatitis and the overall health of the organ.
In recent years, several developing countries such as China and India have witnessed significant economic growth, which has resulted in an increase in GDP at Purchasing Power Parity (PPP) of these countries. The growth in GDP-PPP has led to the development of a middle-class population in terms of their purchasing power. Due to this, the middle-class population is currently adopting quality health products including supplements. This factor is expected to contribute to the growth of the liver health supplements market.
In recent years, manufacturers have increased focus on new product launches to increase their market presence. For instance, in December 2016, Livwell Products LLC launched drinkSMART, a hangover and liver supplement with vitamins. In March 2017, Gaia Herbs launched a line of products, Mushroom plus Herbs Collection. It included five products, namely, Everyday Immune, Mental Clarity, Reishi+Turmeric, Cordyceps+, and Liver Defense.
In 2018, the herbal supplements segment held the largest market share of 61.1%. Supplements with herbal ingredients, such as milk thistle, dandelion, artichoke leaf, turmeric, and mushrooms are widely adopted for liver health. Milk thistle-based supplements are widely adopted by consumers as milk thistle has been proved to be beneficial for liver health. Moreover, increasing awareness and benefits of natural products in countries, such as the U.S. and India is supporting the segment growth. Mushroom-based supplements are also anticipated to continue gaining momentum in terms of demand among consumers. Reishi and Chaga mushroom is considered to be an ideal herb for detoxification.
Vitamins and minerals segment is anticipated to expand at the highest CAGR of 4.81% over the forecast period. Vitamins, such as vitamin A, vitamin D, vitamin E, and vitamin B12 are beneficial for the health of digestive organs. Recently, increasing consumption of vitamin supplements to maintain body health and wellbeing, owing to the adoption of a sedentary lifestyle; is anticipated to support the market growth.
Capsules segment accounted for the largest revenue share of 41.0% in 2018. Capsule is a widely accepted dosage form as it enables the ingredients to mix in a single dosage form. The segment is expected to expand at the fastest CAGR over the forecast period. Capsules provide protection from sensitive ingredients to the stomach lining and reduce gastrointestinal irritation. Growing awareness among consumers regarding the advantage of capsule formulations is further fueling the demand for these supplements in capsule form, boosting the growth of the segment.
Tablets as a dosage form are preferred due to their high shelf life. Currently, there are many domestic as well as international brands developing liver supplements in the form of capsules and tablets. Moreover, supplements in the form of liquids are becoming popular among children with diseases of the digestive system.
Powders segment is expected to register a CAGR of 4.51% over the forecasted period. Various benefits of this dosage form, such as quick absorbability and easy way of consumption among others are anticipated to fuel the demand in near future. These supplements can be mixed into beverages, such as smoothies. Key market players such as the Himalaya Herbal Healthcare is engaged in developing these products in the powder dosage form.
In 2018, Asia Pacific held the largest market share of nearly 35.5% in terms of revenue. Increasing disposable income, growing prevalence of digestive tract diseases, and rising awareness about nutritional products are some factors contributing to the regional growth. In addition, the growing popularity of personalized nutrition among consumers is projected to contribute to the regional demand for liver health supplements. In 2018, the U.S. accounted for the majority of the regional market share, supported by the high consumer inclination toward nutritional products and the rising prevalence of digestive tract diseases. In addition, the presence of a large number of nutritional product manufacturers is anticipated to aid the North American market.
In Europe, the rising consumption of nutritional products in countries, such as Germany and the U.K., is anticipated to promote the adoption of liver health supplements over the forecast period. In addition, the rising adoption of vitamin products particularly among the working population is expected to have a strong impact on the regional market growth in the near future.
Key players operating in the market are Himalaya Herbal Healthcare; Natures Craft, Swisse; Thompson's (Integria Healthcare); Enzymedica; Nature's Bounty; Jarrow Formulas, Inc.; NOW Foods; Irwin’s Natural; Gaia Herbs; and NUTRALife. Product launches, product differentiation, and geographical expansion are among the key strategies adopted by these companies for gaining a competitive edge in the market.
Report Attribute |
Details |
Market size value in 2020 |
USD 766.44 million |
Revenue forecast in 2025 |
USD 948.61 million |
Growth Rate |
CAGR of 4.32% from 2019 to 2025 |
Base year for estimation |
2018 |
Historical data |
2014 – 2017 |
Forecast period |
2019 – 2025 |
Quantitative units |
Revenue in USD million and CAGR from 2019 to 2025 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, dosage, form, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; Germany; U.K.; France; Italy; Spain; Russia; Japan; China; India; Australia; Singapore; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE |
Key companies profiled |
Himalaya Herbal Healthcare; Natures Craft, Swisse; Thompson's (Integria Healthcare); Enzymedica; Nature's Bounty; Jarrow Formulas, Inc.; NOW Foods; Irwin’s Natural |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research, Inc. has segmented the global liver health supplements market report on the basis of product, dosage form, and region:
Product Outlook (Revenue, USD Million, 2014 - 2025)
Vitamin & Minerals
Herbal Supplements
Others
Dosage Form Outlook (Revenue, USD Million, 2014 - 2025)
Capsules
Tablets
Liquid
Powder
Others
Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
U.S.
Canada
Europe
U.K.
Germany
Spain
Italy
France
Russia
China
Asia Pacific
Japan
India
Australia
Singapore
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
b. The global liver health supplements market size was estimated at USD 735.95 million in 2019 and is expected to reach USD 766.44 million in 2020.
b. The global liver health supplements market is expected to grow at a compound annual growth rate of 4.3% from 2019 to 2025 to reach USD 948.6 million.
b. Herbal supplements dominated the liver health supplements market with a share of 60.9% in 2019. This is attributable to the growing awareness about the benefits of natural products globally.
b. Some key players operating in the liver health supplements market include Himalaya Herbal Healthcare; Natures Craft, Swisse; Thompson's (Integria Healthcare); Enzymedica; Nature's Bounty; Jarrow Formulas, Inc.; NOW Foods, and Irwin’s Natural.
b. Key factors that are driving the market growth include increasing prevalence of liver diseases such as liver cancer, fatty liver disease, and others and rising inclination of consumers toward dietary supplements.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
Multiple therapeutic regimens are being followed across the globe in attempts to come up with a reliable treatment for Covid-19. One line of treatment includes the use of hydroxychloroquine, while a second treatment line focuses to use antiviral drugs used in the disease management of HIV. Both these approaches have surged demand from advanced antivirals and antimalarial drugs. This impacts the drug manufacturers as an off label indication for these drug classes has to be worked upon. At the moment, the WHO has not prescribed any of these approaches, neither they have commented if one is better than the other. The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.